Jill C. Milne - 27 Feb 2026 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
27 Feb 2026
Net transactions value
+$4,620
Form type
4
Filing time
03 Mar 2026, 16:36:58 UTC
Previous filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Milne Jill C. Director 4505 EMPEROR BLVD, SUITE 200, DURHAM /s/ Alane P. Barnes, by power of attorney 03 Mar 2026 0001644246

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $4,620 +528 +3.6% $8.75 15,382 27 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock issued to the reporting person in lieu of 100% of the prorated quarterly cash Board Member retainer of $4,625.